latanoprostene bunod Vyzulta
Selected indexed studies
- Latanoprostene Bunod. (, 2006) [PMID:30000019]
- Newer advances in medical management of glaucoma. (Indian J Ophthalmol, 2022) [PMID:35647957]
- ** (, 2019) [PMID:31742962]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Latanoprostene Bunod. (2006) pubmed
- Latanoprostene bunod: the first nitric oxide-donating antiglaucoma medication. (2025) pubmed
- Latanoprostene Bunod Ophthalmic Solution 0.024%: A Review in Open-Angle Glaucoma and Ocular Hypertension. (2018) pubmed
- Latanoprostene bunod ophthalmic solution 0.024% for IOP lowering in glaucoma and ocular hypertension. (2017) pubmed
- Newer advances in medical management of glaucoma. (2022) pubmed
- Prostaglandins. (2026) pubmed
- PMID:31742962 (2019) pubmed
- PMID:31742961 (2019) pubmed
- PMID:31738493 (2019) pubmed
- Critical evaluation of latanoprostene bunod in the treatment of glaucoma. (2016) pubmed